BCL2 and nonpapillary renal cell carcinoma: Our current work shows miR-4521 is a suppressor in ccRCC progression, interacting with FAM129A via the TIMP-1/MMP2/MMP9 and MDM2/p53/Bcl2/Bax pathways.